Minkyeong Kim

Minkyeong Kim

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2020 in Journal of Movement Disorders
Verified
Journal Article
Open access
PDF file
JMJun Kyu Mun
Jun Kyu Mun
AKAh Reum Kim
Ah Reum Kim
JAJong Hyeon Ahn
Jong Hyeon Ahn
MKMinkyeong Kim
Minkyeong Kim
JCJin Whan Cho
Jin Whan Cho
JYJinyoung Youn
Jinyoung Youn
Although the KMT2B gene was identified as a causative gene for early-onset generalized dystonia, the efficacy of deep brain stimulation (DBS) in KMT2B-related dystonia has not been clearly elucidated. Here, we describe a 28-year-old woman who developed generalized dystonia with developmental delay, microcephaly, short stature, and cognitive decline. She was diagnosed with KMT2B- related dystonia using whole-exome sequencing with a heterozygous frameshift insertion of c.515dupC (p.T172fs) in the KMT2B gene. Oral medications and botulinum toxin injection were not effective. The dystonia markedly improved with bilateral pallidal DBS (the Burke-Fahn-Marsden Dystonia Rating Scale score was reduced from 30 to 5 on the dystonia movement scale and from 11 to 1 on the disability scale), and she could walk independently. From this case, we suggest that bilateral globus pallidus internus DBS can be an effective treatment option for patients with KMT2B-related generalized dystonia.

1 October 2018 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
MKMinkyeong Kim
Minkyeong Kim
KCKyung Rae Cho
Kyung Rae Cho
JPJi-Hyung Park
Ji-Hyung Park
JAJong Hyeon Ahn
Jong Hyeon Ahn
JCJin Whan Cho
Jin Whan Cho
JYJinyoung Youn
Jinyoung Youn

1 January 2025 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
MKMinkyeong Kim
Minkyeong Kim
EKEunji Kim
Eunji Kim
MKMinjun Kim
Minjun Kim
SMSeok Min Moon
Seok Min Moon
MKMinjung Kim
Minjung Kim
HKHeeyoung Kang
Heeyoung Kang
Kim M, et al. J Clin Neurol. 2025 Jan;21(1):13-20. https://doi.org/10.3988/jcn.2024.0328

21 November 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
BLBina Lee
Bina Lee
IIInes Ingabire
Ines Ingabire
JJJIHYUN JE
JIHYUN JE
EPEun Jung Park
Eun Jung Park
HSHyemin Seong
Hyemin Seong
SYSeung Pil Yun
Seung Pil Yun
Acute kidney injury (AKI) is an inflammatory sequence. It can lead to distant organ injury, including damage to the central nervous system (CNS), mediated by increased circulating cytokines and other inflammatory mediators. It can also lead to increased blood–brain barrier (BBB) permeability. However, the effect of AKI on the inflammatory response of the brain has not yet been investigated. Therefore, we observed the effect of AKI on BBB permeability, microglia and astrocyte activation, and neuronal toxicity in the brain. The striatum and ventral midbrain, known to control overall movement, secrete the neurotransmitter dopamine. The activation of microglia and astrocytes present in this area causes neuro-degenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). The activation of astrocytes and microglia in the hippocampus and cerebral cortex, which are responsible for important functions, including memory, learning, concentration, and language, can trigger nerve cell apoptosis. The activation of astrocytes and microglia at this site is also involved in the inflammatory response associated with the accumulation of beta-amyloid. In the situation of kidney ischemia reperfusion (IR)-induced AKI, activation of microglia and astrocytes were observed in the striatum, ventral midbrain, hippocampus, and cortex. However, neuronal cell death was not observed until 48 h.

1 January 2021 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
MKMinkyeong Kim
Minkyeong Kim
JAJong Hyeon Ahn
Jong Hyeon Ahn
JMJun Kyu Mun
Jun Kyu Mun
ECEun-Hyeok Choi
Eun-Hyeok Choi
JKJi Sun Kim
Ji Sun Kim
JCJin Whan Cho
Jin Whan Cho
Kim M, et al. J Clin Neurol. 2021 Apr;17(2):242-248. https://doi.org/10.3988/jcn.2021.17.2.242

13 August 2024 in Journal of Medical Virology
Verified
Journal Article
Open access
SKSeon-Hee Kim
Seon-Hee Kim
HCHa Nyeoung Choi
Ha Nyeoung Choi
MJMin Gi Jo
Min Gi Jo
BLBina Lee
Bina Lee
YKYoung Jin Kim
Young Jin Kim
SYSeung Pil Yun
Seung Pil Yun
Severe fever with thrombocytopenia syndrome (SFTS) has a high mortality rate compared to other infectious diseases. SFTS is particularly associated with a high risk of mortality in immunocompromised individuals, while most patients who die of SFTS exhibit symptoms of severe encephalitis before death. However, the region of brain damage and mechanisms by which the SFTS virus (SFTSV) causes encephalitis remains unknown. Here, we revealed that SFTSV infects the brainstem and spinal cord, which are regions of the brain associated with respiratory function, and motor nerves in IFNAR1‐/‐ mice. Further, we show that A1‐reactive astrocytes are activated, causing nerve cell death, in infected mice. Primary astrocytes of SFTSV‐infected IFNAR1‐/‐ mice also induced neuronal cell death through the activation of A1‐reactive astrocytes. Herein, we showed that SFTSV induces fatal neuroinflammation in the brain regions important for respiratory function and motor nerve, which may underlie mortality in SFTS patients. This study provides new insights for the treatment of SFTS, for which there is currently no therapeutic approach.